1,229
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Effect of lycorine on the structure and function of hepatoma cell membrane in vitro and in vivo

, , , , , , , & show all
Pages 104-114 | Received 04 Jun 2019, Accepted 16 Jan 2020, Published online: 04 Feb 2020

References

  • Tasker SZ, Cowfer AE, Hergenrother PJ. Preparation of structurally diverse compounds from the natural product lycorine. Org Lett. 2018;20(18):5894–5898.
  • Roy M, Liang L, Xiao X, et al. Lycorine: a prospective natural lead for anticancer drug discovery. Biomed Pharmacother. 2018;107:615–624.
  • Hu Z, Wang Z, Liu Y, et al. Leveraging botanical resources for crop protection: the isolation, bioactivity and structure–activity relationships of lycoris alkaloids. Pest Manage Sci. 2018;74(12):2783–2792.
  • Jiang QQ, Liu WB. Lycorine inhibits melanoma A375 cell growth and metastasis through the inactivation of the PI3K/AKT signaling pathway. Med Sci (Paris). 2018;34(F1):33–38.
  • Ji Y, Yu M, Qi Z, et al. Study on apoptosis effect of human breast cancer cell MCF-7 induced by lycorine hydrochloride via death receptor pathway. Saudi Pharm J. 2017;25(4):633–637.
  • Zeng H, Fu R, Yan L, et al. Lycorine induces apoptosis of A549 cells via AMPK-mammalian target of rapamycin (mTOR)-S6K signaling pathway. Med Sci Monit. 2017;23:2035–2041.
  • Zhang W, Cui EH. Study on effect of lycorine in inducing apoptosis of pulmonary carcinoma cell A549. Zhongguo Zhong Yao Za Zhi. 2015;40(16):3278–3282.
  • Li X, Xu P, Wang C, et al. Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma. Oncotarget. 2017;8(13):21177–21186.
  • Cao Z, Yu D, Fu S, et al. Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicol Lett. 2013;218(2):174–185.
  • Li L, Dai HJ, Ye M, et al. Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition. Cancer Cell Int. 2012;12(1):49.
  • Liu J, Hu JL, Shi BW, et al. Up-regulation of p21 and TNF-alpha is mediated in lycorine-induced death of HL-60 cells. Cancer Cell Int. 2010;10:25.
  • Ji CF, Ji YB. Effect of asparagus polysaccharide on erythrocyte membrane components and fluidity in S180 mice. Tianjin Tradit Chin Med. 2009;26(06):479–482.
  • Ji YB, Ji CF, Ma HT. Effects of ethanol extracts from qinglongyi on the biochemical function of tumor cell membrane in H22 mice. Chin J Tradit Chin Med. 2005;30(07):531–534.
  • Ji YB, Wang SH, Gao SY, et al. Effects of anemone on membrane fluidity and membrane protein level in H22 tumor-bearing mice. J Chin Herb Med. 2005;0(02):239–241.
  • Ji YB, Wang SH, Gao SY, et al. Effect of anemone on sialic acid and occlusion of cell membrane of H_(22) tumor-bearing mice. J Chin Herb Med. 2005;(01):79–81.
  • Ji YB, Ji CF. Effect of astragalus polysaccharide on erythrocyte immune function in tumor model mice. J Mod Food Sci Technol. 2013;29(09):2042–2046, 2052.
  • Song GL, Wang JB, Du QB, et al. Study on changes of S180 sarcoma cell membrane characteristics by auricularia auriculata polysaccharide. Chin J Pharm. 2012;47(04):255–261.
  • Hu QL, Feng ZY. Effect of polysaccharides from cactus on lipid fluidity of tumor cell membrane. Mod Chin. Tradit Med. 2006;(11):17–19.
  • Ji YB, Ma HT. Effect of qinglongyi extract on cell membrane fluidity in tumor-bearing mice. J Chin Herb Med. 2004;(12):70–73.
  • Ji YB, Gao SY, Kong Q. Effect of seaweed polysaccharide on the fluidity of tumor cell membrane. J Chin Herb Med. 2002;(05):54–56.
  • Ji YB, Chen HJ, Ji CF. Effect of qinglongyi polysaccharide on ATPase activity of H22 tumor cells. J Drug Eval. 2006;(06):412–415.
  • Ji YB, Gao SY, Wang HL, et al. Effect of total alkaloid of nightingale on the activity of sodium pump and calcium pump of tumor cell membrane was studied. World J Sci. Technol. 2006;(04):40–43.
  • Wang ZJ, Qiao P, Fan HK, et al. Effect of pyrimidine on sodium pump activity of S180, EAC and H22tumor cell membrane in mice. Chin J Pract Neurol Dis. 2006;0(02):17–18.
  • Evdokimov NM, Lamoral-Theys D, Mathieu V, et al. In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives. Bioorg Med Chem. 2011;19(23):7252–7261.
  • Chen S, Jin G, Huang K-M, et al. Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo. Sci Rep. 2015;5:12853.
  • Roy M, Liang L, Xiao X, et al. Lycorine downregulates HMGB1 to inhibit autophagy and enhances bortezomib activity in multiple myeloma. Theranostics. 2016;6(12):2209–2224.
  • Ilavenil S, Kaleeswaran B, Sumitha P, et al. Protection of human erythrocyte using Crinumasiaticum extract and lycorine from oxidative damage induced by 2-amidinopropane. Saudi J Biol Sci. 2011;18(2):181–187.
  • Wang Y-H, Wan Q-L, Gu C-D, et al. Synthesis and biological evaluation of lycorine derivatives as dual inhibitors of human acetylcholinesterase and butyrylcholinesterase. Chem Cent J. 2012; 6:96.
  • Misaghian N, Ligresti G, Steelman LS, et al. Targetting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia. 2009;23(l):25–42.